Intellia Therapeutics (NTLA) PT Lowered to $70 at Oppenheimer
Tweet
Share
E-mailGet Alerts NTLA Hot Sheet
Price: $11.91 +0.68%
Rating Summary:
23 Buy, 9 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
23 Buy, 9 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Oppenheimer analyst Jay Olson lowered the price target on Intellia Therapeutics (NASDAQ: NTLA) to $70.00 (from $80.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- GMR Airports Infrastructure (GMRI:IN) PT Raised to INR99 at ICICI Securities
- Petronet LNG Ltd. (PLNG:IN) PT Raised to INR310 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
